However, the effect of driver gene mutations, especially NF2 alteration, on the prognosis of meningiomas has not been clearly established, except a few reports stating that their prognosis in all WHO grade meningiomas differs depending on the epigenomic/transcriptomic profiles [26–31]. Here, NF2 is linked to meningioma.